99240392 - TANGRAM

Information

• Trademark
• 99240392

• Source

• Serial Number

  99240392

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  June 18, 2025
  4 months ago

• Transaction Date

  June 19, 2025
  3 months ago

• Status Date

  June 18, 2025
  4 months ago

• Status Code

  630

• Attorney Docket Number

  009867.00018

  Attorney Name

  Anna King

• Owners

  • E-THERAPEUTICS PLC

Case File Statements

• GS0401: Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid.
• DM0000: The mark consists of the word “TANGRAM” in stylized font.
• GS0091: Computer software; downloadable computer software; computer software for use in the field of pharmaceuticals, medicines and drug discovery; artificial intelligence and machine learning software; artificial intelligence and machine learning software for use in the field of pharmaceuticals, medicines and drug discovery; databases; electronic databases for use in the field of pharmaceuticals, medicines and drug discovery; computer platform software; computer software platforms; computer platform software platforms for use in the field of pharmaceuticals, medicines and drug discovery; computer software platforms for use in the field of pharmaceuticals, medicines and drug discovery.
• GS0051: Pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals; short interfering RNA (siRNA) medicines and pharmaceuticals; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation.
• GS0421: Scientific research and development; pharmaceutical research and development services; drug discovery services; human genetic research; scientific and technical data analysis in the field of pharmaceuticals, medicines and drug discovery; design, development, creation and maintenance of computer software platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) featuring computer software platforms for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; design and development of computer-simulated models; Software as a Service (SaaS); provision of information, advice and consultancy services relating to all of the aforesaid.

Case File Event Statements

• 6/18/2025 - 4 months ago

  1 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/18/2025 - 4 months ago

  2 - NEW APPLICATION ENTERED Type: NWAP